Journal
JOURNAL OF PAIN RESEARCH
Volume 14, Issue -, Pages 61-72Publisher
DOVE MEDICAL PRESS LTD
DOI: 10.2147/JPR.S241893
Keywords
epoxy fatty acids; chronic pain; molecular mechanisms
Categories
Funding
- National Institute of Environmental Health Sciences (NIEHS) [R35ES030443]
- NIEHS Superfund Research Program [P42 ES004699]
Ask authors/readers for more resources
Chronic pain is a complex condition with significant physical, emotional, and financial impacts. Current treatments are insufficient due to high cost and safety issues. Inhibition of soluble epoxide hydrolase (sEH) as a therapeutic target could enhance the beneficial effects of natural epoxy-fatty acids (EpFAs) in pain management.
Chronic pain is a complicated condition which causes substantial physical, emotional, and financial impacts on individuals and society. However, due to high cost, lack of efficacy and safety problems, current treatments are insufficient. There is a clear unmet medical need for safe, nonaddictive and effective therapies in the management of pain. Epoxy-fatty acids (EpFAs), which are natural signaling molecules, play key roles in mediation of both inflammatory and neuropathic pain sensation. However, their molecular mechanisms of action remain largely unknown. Soluble epoxide hydrolase (sEH) rapidly converts EpFAs into less bioactive fatty acid diols in vivo; therefore, inhibition of sEH is an emerging therapeutic target to enhance the beneficial effect of natural EpFAs. In this review, we will discuss sEH inhibition as an analgesic strategy for pain management and the underlying molecular mechanisms.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available